Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2022 | The management of cytopenias in MF

Prithviraj Bose • 10 Nov 2022
Texas MPN Workshop 2022
Myelofibrosis Myeloproliferative Neoplasms Luspatercept Pelabresib Ruxolitinib
COMFORT-I MANIFEST-2 PERSIST-2 SIMPLIFY-2

Prithviraj Bose, MBBS, The University of Texas MD Anderson Cancer Center, Houston, TX, gives a presentation on the management of cytopenias in myelofibrosis (MF) at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

More from Prithviraj Bose

2:55
Current and emerging treatments for MF: an update from ASH 2023
Prithviraj Bose • 11 Dec 2023
2:21
An update from LIMBER-104: zilurgisertib +/- ruxolitinib in the management of MF-associated anemia
Prithviraj Bose • 11 Dec 2023
3:49
Bezuclastinib in adult patients with non-advanced systemic mastocytosis: initial results from Summit
Prithviraj Bose • 11 Dec 2023
3:30
LIMBER-104: zilurgisertib +/- ruxolitinib in patients with MF-associated anemia
Prithviraj Bose • 6 Sep 2023

Related Videos

1:13
The current BSH guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
Mary Frances McMullin • 28 Apr 2024
1:46
Updated analyses from the PATHFINDER trial: avapritinib therapy in advanced systemic mastocytosis
Deepti Radia • 29 Apr 2024
4:32
Current trials in MPN in the UK and the launch of the My MPN Voice app
Claire Harrison • 29 Apr 2024
2:42
The management of myelofibrosis in patients with moderate to severe anemia
Mary Frances McMullin • 28 Apr 2024
The content of VJHemOnc is intended for healthcare professionals